TY - JOUR
T1 - Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography
T2 - Comparison With 101 Radiologists
AU - Rodriguez-Ruiz, Alejandro
AU - Lång, Kristina
AU - Gubern-Merida, Albert
AU - Broeders, Mireille
AU - Gennaro, Gisella
AU - Clauser, Paola
AU - Helbich, Thomas H.
AU - Chevalier, Margarita
AU - Tan, Tao
AU - Mertelmeier, Thomas
AU - Wallis, Matthew G.
AU - Andersson, Ingvar
AU - Zackrisson, Sophia
AU - Mann, Ritse M.
AU - Sechopoulos, Ioannis
N1 - Publisher Copyright:
© The Author(s) 2019. Published by Oxford University Press. All rights reserved.
PY - 2019/9/1
Y1 - 2019/9/1
N2 - Background: Artificial intelligence (AI) systems performing at radiologist-like levels in the evaluation of digital mammography (DM) would improve breast cancer screening accuracy and efficiency. We aimed to compare the stand-alone performance of an AI system to that of radiologists in detecting breast cancer in DM. Methods: Nine multi-reader, multi-case study datasets previously used for different research purposes in seven countries were collected. Each dataset consisted of DM exams acquired with systems from four different vendors, multiple radiologists’ assessments per exam, and ground truth verified by histopathological analysis or follow-up, yielding a total of 2652 exams (653 malignant) and interpretations by 101 radiologists (28 296 independent interpretations). An AI system analyzed these exams yielding a level of suspicion of cancer present between 1 and 10. The detection performance between the radiologists and the AI system was compared using a noninferiority null hypothesis at a margin of 0.05. Results: The performance of the AI system was statistically noninferior to that of the average of the 101 radiologists. The AI system had a 0.840 (95% confidence interval [CI] ¼ 0.820 to 0.860) area under the ROC curve and the average of the radiologists was 0.814 (95% CI ¼ 0.787 to 0.841) (difference 95% CI ¼ -0.003 to 0.055). The AI system had an AUC higher than 61.4% of the radiologists. Conclusions: The evaluated AI system achieved a cancer detection accuracy comparable to an average breast radiologist in this retrospective setting. Although promising, the performance and impact of such a system in a screening setting needs further investigation.
AB - Background: Artificial intelligence (AI) systems performing at radiologist-like levels in the evaluation of digital mammography (DM) would improve breast cancer screening accuracy and efficiency. We aimed to compare the stand-alone performance of an AI system to that of radiologists in detecting breast cancer in DM. Methods: Nine multi-reader, multi-case study datasets previously used for different research purposes in seven countries were collected. Each dataset consisted of DM exams acquired with systems from four different vendors, multiple radiologists’ assessments per exam, and ground truth verified by histopathological analysis or follow-up, yielding a total of 2652 exams (653 malignant) and interpretations by 101 radiologists (28 296 independent interpretations). An AI system analyzed these exams yielding a level of suspicion of cancer present between 1 and 10. The detection performance between the radiologists and the AI system was compared using a noninferiority null hypothesis at a margin of 0.05. Results: The performance of the AI system was statistically noninferior to that of the average of the 101 radiologists. The AI system had a 0.840 (95% confidence interval [CI] ¼ 0.820 to 0.860) area under the ROC curve and the average of the radiologists was 0.814 (95% CI ¼ 0.787 to 0.841) (difference 95% CI ¼ -0.003 to 0.055). The AI system had an AUC higher than 61.4% of the radiologists. Conclusions: The evaluated AI system achieved a cancer detection accuracy comparable to an average breast radiologist in this retrospective setting. Although promising, the performance and impact of such a system in a screening setting needs further investigation.
UR - http://www.scopus.com/inward/record.url?scp=85064590651&partnerID=8YFLogxK
U2 - 10.1093/JNCI/DJY222
DO - 10.1093/JNCI/DJY222
M3 - Article
C2 - 30834436
AN - SCOPUS:85064590651
SN - 0027-8874
VL - 111
SP - 916
EP - 922
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 9
ER -